glucosamine has been researched along with Cancer of Prostate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, YW; Li, FX; Lin, TF; Liu, D; Sha, F; Tang, JL; Wei, C; Yang, ZR; Yang, ZY; Zhao, HY; Zhao, ZY | 1 |
Alyamani, M; Berk, M; Chung, YM; Cui, D; Goudarzi, M; Han, B; Hardaway, A; Li, J; McManus, J; Sharifi, N; Tiwari, R; Valle, S; Willard, B; Zhu, Z | 1 |
Cocchiola, R; de Santi, MM; Eufemi, M; Guazzo, R; Lopreiato, M; Scandurra, R; Scotto d'Abusco, A | 1 |
Baek, WK; Park, JW; Park, JY; Suh, SI | 1 |
Kou, YR; Lee, TS; Tsai, CY; Wu, YL | 1 |
Brasky, TM; Kristal, AR; Lampe, JW; Navarro, SL; Patterson, RE; Peters, U; White, E | 1 |
Gao, YY; Guan, Y; Li, C; Li, N; Liu, BQ; Meng, X; Niu, XF; Wang, HQ | 1 |
Achilefu, S; Chen, Y; Huang, S; Korotcov, AV; Lin, S; Sridhar, R; Wang, PC; Ye, Y; Zhang, F | 1 |
8 other study(ies) available for glucosamine and Cancer of Prostate
Article | Year |
---|---|
Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort.
Topics: Dietary Supplements; Glucosamine; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Skin Neoplasms | 2023 |
Cancer-associated fibroblast-secreted glucosamine alters the androgen biosynthesis program in prostate cancer via HSD3B1 upregulation.
Topics: Androgen Antagonists; Androgens; Cancer-Associated Fibroblasts; Cell Line, Tumor; Glucosamine; Humans; Male; Multienzyme Complexes; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Up-Regulation | 2023 |
The induction of Maspin expression by a glucosamine-derivative has an antiproliferative activity in prostate cancer cell lines.
Topics: Anilides; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Glucosamine; Humans; Male; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Serpins; Tosyl Compounds | 2019 |
D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Down-Regulation; Glucosamine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Prostatic Neoplasms; Protein Transport | 2009 |
Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Coculture Techniques; Gene Expression Regulation, Neoplastic; Glucosamine; Humans; Interleukin-1beta; Interleukin-8; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Receptors, Interleukin-8A; Receptors, Interleukin-8B; RNA, Messenger; Time Factors | 2009 |
Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.
Topics: Aged; Chemoprevention; Chondroitin; Confidence Intervals; Dietary Supplements; Fish Oils; Follow-Up Studies; Garlic; Glucosamine; Grape Seed Extract; Humans; Life Style; Logistic Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; Vitamins | 2011 |
Glucosamine induces cell death via proteasome inhibition in human ALVA41 prostate cancer cell.
Topics: Acetylglucosamine; Alloxan; Apoptosis; Autoantigens; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucosamine; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RNA, Small Interfering; Ubiquitinated Proteins | 2011 |
Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts.
Topics: Animals; Cell Line, Tumor; Endocytosis; Fluorescent Dyes; Glucosamine; Humans; Kinetics; Male; Mice; Mice, Nude; Molecular Imaging; Neoplasms; Optical Devices; Prostatic Neoplasms; Spectroscopy, Near-Infrared; Tissue Distribution; Xenograft Model Antitumor Assays | 2012 |